Oncology / Non-Small Cell Lung Cancer

Biomarkers for Response to Immune Checkpoint Inhibition

clinical topic updates by Bruce E. Johnson, MD

Immunotherapy has revolutionized the treatment of non–small cell lung cancer (NSCLC). Programmed cell death-ligand 1 (PD-L1) and tumor mutation bur......READ MORE

Non-Small Cell Lung Cancer

Newer Targets and Therapies for Non–Small Cell Lung Cancer

expert roundtables by Jeffrey Crawford, MD; Bruce E. Johnson, MD; and Gregory J. Riely, MD, PhD

Chronic Myeloid Leukemia

Initial Approach to Newly Diagnosed Patients With Chronic Myeloid Leukemia

expert roundtables by Gabriela S. Hobbs, MD; Mark J. Levis, MD, PhD; and Neil P. Shah, MD, PhD

LATEST IN Oncology

Browse More Articles